Lawsuits alleging that the osteoporosis drug Fosamax causes bone fractures have been consolidated in multidistrict litigation in federal court in New Jersey. About three dozen fracture lawsuits are pending in federal courts around the country. The MDL will also include new Complaints over femur fractures. These lawsuits will be overseen by U.S. District Court Judge Garrett E. Brown, Jr. The suits allege that Merck, the maker of Fosamax, failed to warn that the drug poses a higher risk of thigh bone fractures even with low impact.
In October, the FDA issued a warning about atypical femur fractures from Fosamax and other bisphosphonates, and required new labeling on the medications. Meanwhile, bellwether cases are still being tried in an earlier MDL involving Fosamax and different injuries. Those cases, which number around 1,000, allege that Fosamax causes osteonecrosis, or “jaw death” syndrome. Those trials have had mixed results, but more are being planned for trials for this year.
Lawyers in our firm’s Mass Torts Section have handled a number of Fosamax cases for women who were severely injured as a result of taking Fosamax. If you need more information on this subject, contact Chad Cook, a lawyer in our firm’s Mass Torts Section, at 800-898-2034 or by email at Chad.Cook@beasleyallen.com.
Source: Lawyers USA Online
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.